Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue

E-ISSN： 1875-533x|25|11|1327-1339

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.25, Iss.11, 2018-04, pp. : 1327-1339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety

Current Cancer Drug Targets, Vol. 15, Iss. 6, 2015-01 ,pp. : 452-462

Bentham Science Publishers

Access to resources Recommend Favorite

Kinase inhibitors and immune check-point blockade for the treatment of metastatic melanoma and advanced cancer: synergistic or antagonistic?

By Luke Jason John Ott Patrick Alexander

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 18, 2013-12 ,pp. : 2457-2462

Informa Healthcare

Access to resources Recommend Favorite

Current Inhibitors of Checkpoint Kinase 2

Current Medicinal Chemistry, Vol. 18, Iss. 28, 2011-10 ,pp. : 4368-4374

Bentham Science Publishers

Access to resources Recommend Favorite

Checkpoint kinase inhibitors: a patent review (2009 –– 2010)

By Lainchbury Michael Collins Ian

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 8, 2011-08 ,pp. : 1191-1210

Informa Healthcare

Access to resources Recommend Favorite

Toxicity of the topoisomerase II inhibitors

By Seiter Karen

Expert Opinion on Drug Safety, Vol. 4, Iss. 2, 2005-03 ,pp. : 219-234

Informa Healthcare

Access to resources Recommend Favorite